Resources

Understanding the Post COVID‑19 Condition (Long COVID) and the Expected Burden for Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 14, 2021

The Incidence, Severity, and Management of COVID‑19 in Critically Ill Pregnant Individuals

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 13, 2021

The Impact of the COVID‑19 Pandemic on Opioid-Related Harm in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 8, 2021

Heparin Anticoagulation for Hospitalized Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 3, 2021

Effectiveness of Rehabilitation Interventions for People with Long COVID

Product: — Evidence Synthesis Network

Long Covid Signs & Symptoms

esnetwork.ca Last Updated: July 10, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021

Understanding Long COVID-19

Product: — Evidence Synthesis Network

Long Covid Signs & Symptoms

esnetwork.ca Last Updated: May 7, 2021

Long COVID‑19 Clinics

Product: — Evidence Synthesis Network

Long Covid Regulation & Policy Workplace Regulations

esnetwork.ca Last Updated: April 27, 2021

Understanding Long COVID-19

Product: — Evidence Synthesis Network

Long Covid Signs & Symptoms

esnetwork.ca Last Updated: April 7, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Treatments

covid19-sciencetable.ca Last Updated: February 25, 2021